Antimicrobial Agents Practice Questions

Q: All of the following drugs are effective for treatment of hookworm infection in single dose EXCEPT:

Piperazine. ***Piperazine*** - **Piperazine** is primarily effective against **Ascaris lumbricoides** and **Enterobius vermicularis**, acting as a depolarizing neuromuscular blocker. - It is **not effective** against hookworm infections and is therefore unsuitable for treating the human reservoir of hookworms. *Albendazole* - **Albendazole** is a broad-spectrum anthelminthic highly effective against hookworm infections, including **Necator americanus** and **Ancylostoma duodenale**. - A **single dose** is often sufficient due to its effectiveness in eliminating adult worms and reducing egg excretion. *Levamisole* - **Levamisole** is an anthelminthic that can be effective against hookworm species, working as a **ganglionic stimulant** causing paralysis of the worms. - A **single dose** regimen is typically adequate for hookworm treatment. *Pyrantel* - **Pyrantel pamoate** is effective against hookworms by causing **neuromuscular blockade**, leading to expulsion of the worms. - It is often given as a **single dose** for effective treatment of hookworm infections.

Q: The drug of choice for chemoprophylaxis to health care personnel and close contacts of suspected or confirmed case of pandemic influenza A (H1N1) is:

Oseltamivir. ***Oseltamivir*** - **Oseltamivir** is the recommended drug for chemoprophylaxis against pandemic influenza A (H1N1) for healthcare personnel and close contacts [1, 2]. - This recommendation is based on its effectiveness against the **neuraminidase** of the H1N1 virus, preventing viral release and spread. *Ribavirin* - **Ribavirin** is an antiviral agent used for conditions like chronic hepatitis C and RSV, but it is not recommended for influenza chemoprophylaxis. - Its mechanism of action and efficacy profile do not make it a primary choice for preventing H1N1 infection. *Amantadine* - **Amantadine** targets the M2 ion channel of influenza A viruses, but many H1N1 strains, including the pandemic strain, developed **resistance** to this drug [1]. - Due to widespread resistance, **amantadine** and rimantadine are no longer recommended for routine influenza treatment or prophylaxis [1]. *Zanamivir* - **Zanamivir** is another **neuraminidase inhibitor** effective against influenza A and B, but it is administered via inhalation. - While effective, **oseltamivir** is generally preferred for chemoprophylaxis due to its oral administration, making it more convenient for widespread use [2].

Q: Which one of the following is the antibiotic of choice for the prevention of Rheumatic Heart Disease?

Benzathine Benzyl Penicillin. ***Benzathine Benzyl Penicillin*** - It is the antibiotic of choice for the **prevention of Rheumatic Heart Disease (RHD)** due to its **long-acting nature** and effectiveness against **Group A Streptococcus (GAS)**. - A single intramuscular injection provides **sustained therapeutic levels** for several weeks, crucial for preventing recurrent GAS infections that lead to RHD. *Doxycycline* - Not effective for **primary prevention of Rheumatic Fever** or RHD as it is not a first-line agent against **Group A Streptococcus**. - Mainly used for **atypical bacteria** and certain parasitic infections. *Procaine Penicillin* - It has a shorter duration of action compared to **benzathine penicillin**. - Requires more frequent injections, making it less suitable for **long-term prophylaxis** in RHD prevention. *Ciprofloxacin* - This is a **fluoroquinolone antibiotic** and is not the antibiotic of choice for **Group A Streptococcus infections**. - Its use in this context could contribute to **antibiotic resistance** without providing effective prophylaxis for RHD.

Q: All of the following are true about Bedaquiline (BDQ) EXCEPT:

It is a bacteriostatic drug. ***It is a bacteriostatic drug*** - **Bedaquiline (BDQ)** is a novel anti-tuberculosis drug that is **bactericidal** against *Mycobacterium tuberculosis*, meaning it kills the bacteria rather than just inhibiting their growth. - Its bactericidal action is crucial for treating multi-drug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis. *It has extended half-life* - **Bedaquiline** has a very **long terminal elimination half-life**, which can extend up to several months. - This extended half-life allows for less frequent dosing schedules (e.g., once daily or thrice weekly after an initial loading phase). *It specifically targets mycobacterial ATP synthase* - **Bedaquiline** specifically inhibits **mycobacterial ATP synthase**, an enzyme essential for energy production in *Mycobacterium tuberculosis* [1]. - This unique mechanism of action contributes to its effectiveness against traditional drug-resistant strains [1]. *It has high volume of tissue distribution* - **Bedaquiline** is highly lipophilic and extensively distributed into tissues, resulting in a **large volume of distribution**. - This extensive tissue distribution contributes to its long half-life and allows it to reach therapeutic concentrations within the infection sites.

Q: Why is ceftriaxone preferred over penicillin for gonorrhea treatment despite both being effective in vitro?

Lower resistance rates. ***Lower resistance rates*** - The **primary reason** ceftriaxone is preferred over penicillin for gonorrhea is the **widespread emergence of penicillinase-producing *Neisseria gonorrhoeae* (PPNG)** strains and chromosomally-mediated resistance - Penicillin resistance in *N. gonorrhoeae* now exceeds **50-90%** in many regions globally, making penicillin ineffective for empirical treatment - **Ceftriaxone** and other third-generation cephalosporins maintain **high efficacy** against most gonorrhea strains, though emerging cephalosporin resistance is a growing concern - Current **CDC and WHO guidelines** recommend ceftriaxone as first-line therapy specifically because of superior antimicrobial activity against resistant strains *Single-dose convenience* - While ceftriaxone's **single intramuscular dose** regimen does improve patient adherence and treatment completion, this is a **secondary advantage** - Convenience is clinically irrelevant if the drug is ineffective due to resistance - The single-dose feature enhances the utility of ceftriaxone but is not the fundamental reason for its preference over penicillin *Lower risk of allergic reactions* - Ceftriaxone does not have a significantly lower risk of allergic reactions compared to penicillin - Both penicillins and cephalosporins share a **beta-lactam structure**, leading to potential **cross-reactivity** (5-10% in penicillin-allergic patients) - Allergy considerations are important for individual patient selection but do not explain the population-level preference for ceftriaxone *Better tissue penetration* - Both **ceftriaxone** and penicillin achieve adequate tissue penetration at sites of gonorrheal infection (urethra, cervix, rectum, pharynx) - Ceftriaxone does have excellent CNS penetration and longer half-life, but tissue penetration differences are **not the primary factor** in choosing it over penicillin for uncomplicated gonorrhea

Q: A 30-year-old woman presents with breakthrough genital herpes outbreaks despite appropriate suppressive therapy. She is HIV-negative and reports adherence to medication. What is the most likely explanation?

Acyclovir-resistant HSV strain. **Acyclovir-resistant HSV strain** - Given recurrent outbreaks despite suppressive therapy and reported adherence, **drug resistance (e.g., acyclovir resistance)** is the most likely explanation for treatment failure [1]. - Acyclovir resistance typically occurs due to mutations in the **viral thymidine kinase gene**, preventing activation of the drug [1]. *Immunologic factors reducing drug efficacy* - While underlying immune status can affect herpes recurrence, the patient is **HIV-negative**, suggesting a relatively intact immune system. - Suppressive therapy is designed to overcome standard immune responses, so general immunologic factors alone are less likely to cause complete suppressive failure in an otherwise healthy individual [2]. *Incorrect diagnosis of herpes* - Recurrent genital lesions often lead to a high suspicion of herpes, and the initiation of suppressive therapy implies a **prior clinical diagnosis**. - While misdiagnosis is possible, given the history of recurrent outbreaks and *initiation of suppressive therapy*, an incorrect diagnosis is less probable than resistance when the treatment itself is failing. *Superinfection with a different HSV type* - While possible, superinfection with another HSV type (e.g., HSV-1 if initially HSV-2, or vice versa) would typically present with **new primary-like symptoms** or a renewed pattern of outbreaks, not necessarily a direct failure of *ongoing suppressive therapy* for the existing type. - Suppressive therapy against one HSV type usually offers *some cross-protection* or at least would not completely fail against the *original* type due to a new infection.

Q: Which oral antibiotic is contraindicated in pregnant women with chlamydial infection?

Doxycycline. ***Doxycycline*** - **Doxycycline** is contraindicated in pregnant women due to its potential to cause **permanent tooth discoloration** (yellow-brown staining) and **enamel hypoplasia** in the fetus. - It can also inhibit **bone growth** if used during pregnancy, making it an unsuitable choice for chlamydial infection in this population. *Azithromycin* - **Azithromycin** is generally considered safe and is a recommended treatment for **chlamydial infection in pregnant women**. - It is a **macrolide antibiotic** and does not have the teratogenic effects associated with tetracyclines like doxycycline. *Amoxicillin* - **Amoxicillin** is a **penicillin-class antibiotic** and is considered safe for use during pregnancy. - While it can be used for some infections in pregnancy, it is not the primary treatment for **chlamydial infections**, for which macrolides are preferred. *Erythromycin* - **Erythromycin** is another **macrolide antibiotic** that is considered safe for use in pregnant women. - It is an alternative treatment option for **chlamydial infection during pregnancy**, particularly if azithromycin is not tolerated.

Q: What is the mechanism of action of acyclovir in treating herpes infections?

Inhibits viral DNA polymerase after phosphorylation. ***Inhibits viral DNA polymerase after phosphorylation*** - Acyclovir is a **prodrug** that requires activation by viral thymidine kinase, converting it to acyclovir monophosphate. - Subsequent phosphorylation by cellular enzymes forms acyclovir triphosphate, which then competitively inhibits and **inactivates viral DNA polymerase**, terminating DNA chain synthesis. *Inhibits viral reverse transcriptase* - **Reverse transcriptase inhibitors** are primarily used in the treatment of **HIV infections**, as HIV is a retrovirus that utilizes reverse transcriptase for replication. - Herpesviruses are DNA viruses and their replication does not involve a reverse transcriptase enzyme. *Prevents viral attachment to host cells* - This mechanism is characteristic of some **antiviral drugs** that target viral glycoproteins or host cell receptors to block the initial step of infection. - Acyclovir primarily acts intracellularly once the virus has already entered the host cell. *Blocks release of mature virions* - This mechanism is seen with **neuraminidase inhibitors** used for **influenza**, which prevent the budding and release of new viral particles from infected cells. - Acyclovir's action occurs earlier in the viral replication cycle, specifically at the DNA synthesis stage.

Q: Which nomogram scale is used for aminoglycoside dosage?

Hartford nomogram. ***Hartford nomogram*** - The **Hartford nomogram** is the standard tool for determining **once-daily (extended-interval) aminoglycoside dosing** based on **creatinine clearance**. - It helps clinicians optimize aminoglycoside therapy by allowing for less frequent dosing while maintaining therapeutic drug levels and minimizing **nephrotoxicity** and **ototoxicity**. - Developed at Hartford Hospital, this nomogram guides dosing intervals (24, 36, or 48 hours) based on a single serum level drawn 6-14 hours post-dose. *Hallstead scale* - The **Hallstead scale** is not a standard nomogram used in clinical practice for drug dosing. - This term does not correspond to a recognized clinical tool for medication management or aminoglycoside therapy. *Salazar scale* - The **Salazar-Corcoran equation** is used for estimating **creatinine clearance in obese patients**, not as a nomogram for aminoglycoside dosing. - While it may be used in the pharmacokinetic assessment before aminoglycoside dosing, it is not a dosing nomogram itself. *Rumack Matthew nomogram* - The **Rumack-Matthew nomogram** is used for assessing the risk of **hepatotoxicity** after an **acetaminophen overdose** by plotting plasma acetaminophen levels against time. - It is not used for aminoglycoside dosage or therapeutic drug monitoring.

Q: Antimicrobial combinations are used in all except

Gonorrhea. ***Gonorrhea*** - While **gonorrhea** treatment has evolved to include **dual therapy** (e.g., ceftriaxone + azithromycin), this is primarily for co-treatment of potential Chlamydia co-infection and to combat emerging resistance, given as a **single-session treatment**. - Unlike the other conditions, gonorrhea does not require a **prolonged multi-drug regimen** with true synergy or prevention of resistance development during treatment. - The combination is more about empiric co-coverage and resistance concerns rather than the classic indications for antimicrobial combinations (synergy, preventing resistance emergence during therapy, polymicrobial coverage). - This distinguishes it from conditions requiring extended combination therapy. *Intra-abdominal infections* - Involve **polymicrobial etiology** requiring combination therapy to cover both aerobic (e.g., Enterobacteriaceae) and anaerobic bacteria (e.g., Bacteroides fragilis). - Combination therapy ensures broad-spectrum coverage for mixed infections and prevents treatment failures in complex intra-abdominal sepsis. *Malaria* - **Artemisinin-based combination therapies (ACTs)** are the standard first-line treatment for uncomplicated *Plasmodium falciparum* malaria. - Combination therapy reduces drug resistance risk and improves cure rates by targeting different mechanisms of action against the parasite. *Tuberculosis* - Treatment always involves **multi-drug regimen** (isoniazid, rifampicin, pyrazinamide, ethambutol) to prevent emergence of drug-resistant strains. - Multi-drug therapy is essential because *Mycobacterium tuberculosis* rapidly develops resistance if exposed to single agents during the prolonged treatment course.

Question 1

All of the following drugs are effective for treatment of hookworm infection in single dose EXCEPT:

Accepted Answer

Piperazine

Answer

Albendazole

Answer

Levamisole

Answer

Pyrantel

Question 2

The drug of choice for chemoprophylaxis to health care personnel and close contacts of suspected or confirmed case of pandemic influenza A (H1N1) is:

Accepted Answer

Oseltamivir

Answer

Ribavirin

Answer

Amantadine

Answer

Zanamivir

Question 3

Which one of the following is the antibiotic of choice for the prevention of Rheumatic Heart Disease?

Accepted Answer

Benzathine Benzyl Penicillin

Answer

Doxycycline

Answer

Procaine Penicillin

Answer

Ciprofloxacin

Question 4

All of the following are true about Bedaquiline (BDQ) EXCEPT:

Accepted Answer

It is a bacteriostatic drug

Answer

It has extended half life

Answer

It specifically targets mycobacterial ATP synthase

Answer

It has high volume of tissue distribution

Question 5

Why is ceftriaxone preferred over penicillin for gonorrhea treatment despite both being effective in vitro?

Accepted Answer

Lower resistance rates

Answer

Single-dose convenience

Answer

Better tissue penetration

Answer

Lower risk of allergic reactions

Question 6

A 30-year-old woman presents with breakthrough genital herpes outbreaks despite appropriate suppressive therapy. She is HIV-negative and reports adherence to medication. What is the most likely explanation?

Accepted Answer

Acyclovir-resistant HSV strain

Answer

Immunologic factors reducing drug efficacy

Answer

Incorrect diagnosis of herpes

Answer

Superinfection with a different HSV type

Question 7

Which oral antibiotic is contraindicated in pregnant women with chlamydial infection?

Accepted Answer

Doxycycline

Answer

Azithromycin

Answer

Amoxicillin

Answer

Erythromycin

Question 8

What is the mechanism of action of acyclovir in treating herpes infections?

Accepted Answer

Inhibits viral DNA polymerase after phosphorylation

Answer

Inhibits viral reverse transcriptase

Answer

Prevents viral attachment to host cells

Answer

Blocks release of mature virions

Question 9

Which nomogram scale is used for aminoglycoside dosage?

Accepted Answer

Hartford nomogram

Answer

Hallstead scale

Answer

Salazar scale

Answer

Rumack Matthew nomogram

Question 10

Antimicrobial combinations are used in all except

Accepted Answer

Gonorrhea

Answer

Intra abdominal infections

Answer

Malaria

Answer

Tuberculosis

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?